A multicentre evaluation exploring the impact of an integrated health and social care intervention for the caregivers of ICU survivors.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
24 05 2022
Historique:
received: 09 02 2022
accepted: 06 05 2022
entrez: 24 5 2022
pubmed: 25 5 2022
medline: 27 5 2022
Statut: epublish

Résumé

Caregivers and family members of Intensive Care Unit (ICU) survivors can face emotional problems following patient discharge from hospital. We aimed to evaluate the impact of a multi-centre integrated health and social care intervention, on caregiver and family member outcomes. This study evaluated the impact of the Intensive Care Syndrome: Promoting Independence and Return to Employment (InS:PIRE) programme across 9 sites in Scotland. InS:PIRE is an integrated health and social care intervention. We compared caregivers who attended this programme with a contemporary control group of ICU caregivers (usual care cohort), who did not attend. The primary outcome was anxiety measured via the Hospital Anxiety and Depression Scale at 12 months post-hospital discharge. Secondary outcome measures included depression, carer strain and clinical insomnia. A total of 170 caregivers had data available at 12 months for inclusion in this study; 81 caregivers attended the InS:PIRE intervention and completed outcome measures at 12 months post-hospital discharge. In the usual care cohort of caregivers, 89 completed measures. The two cohorts had similar baseline demographics. After adjustment, those caregivers who attended InS:PIRE demonstrated a significant improvement in symptoms of anxiety (OR: 0.42, 95% CI: 0.20-0.89, p = 0.02), carer strain (OR: 0.39; 95% CI: 0.16-0.98 p = 0.04) and clinical insomnia (OR: 0.40; 95% CI: 0.17-0.77 p < 0.001). There was no significant difference in symptoms of depression at 12 months. This multicentre evaluation has shown that caregivers who attended an integrated health and social care intervention reported improved emotional health and less symptoms of insomnia, 12 months after the delivery of the intervention.

Sections du résumé

BACKGROUND
Caregivers and family members of Intensive Care Unit (ICU) survivors can face emotional problems following patient discharge from hospital. We aimed to evaluate the impact of a multi-centre integrated health and social care intervention, on caregiver and family member outcomes.
METHODS
This study evaluated the impact of the Intensive Care Syndrome: Promoting Independence and Return to Employment (InS:PIRE) programme across 9 sites in Scotland. InS:PIRE is an integrated health and social care intervention. We compared caregivers who attended this programme with a contemporary control group of ICU caregivers (usual care cohort), who did not attend.
RESULTS
The primary outcome was anxiety measured via the Hospital Anxiety and Depression Scale at 12 months post-hospital discharge. Secondary outcome measures included depression, carer strain and clinical insomnia. A total of 170 caregivers had data available at 12 months for inclusion in this study; 81 caregivers attended the InS:PIRE intervention and completed outcome measures at 12 months post-hospital discharge. In the usual care cohort of caregivers, 89 completed measures. The two cohorts had similar baseline demographics. After adjustment, those caregivers who attended InS:PIRE demonstrated a significant improvement in symptoms of anxiety (OR: 0.42, 95% CI: 0.20-0.89, p = 0.02), carer strain (OR: 0.39; 95% CI: 0.16-0.98 p = 0.04) and clinical insomnia (OR: 0.40; 95% CI: 0.17-0.77 p < 0.001). There was no significant difference in symptoms of depression at 12 months.
CONCLUSIONS
This multicentre evaluation has shown that caregivers who attended an integrated health and social care intervention reported improved emotional health and less symptoms of insomnia, 12 months after the delivery of the intervention.

Identifiants

pubmed: 35610616
doi: 10.1186/s13054-022-04014-z
pii: 10.1186/s13054-022-04014-z
pmc: PMC9128318
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

152

Subventions

Organisme : Health Foundation UK
ID : 173544
Organisme : The Institute of Healthcare Improvement Studies
ID : 307748-01/PD-2019-02-16

Informations de copyright

© 2022. The Author(s).

Références

Am J Crit Care. 2011 Jan;20(1):12-22; quiz 23
pubmed: 21196567
Am J Respir Crit Care Med. 2005 May 1;171(9):987-94
pubmed: 15665319
PLoS One. 2017 Nov 29;12(11):e0188028
pubmed: 29186177
Crit Care Med. 2009 Oct;37(10):2702-8
pubmed: 19865004
Crit Care. 2019 May 2;23(1):153
pubmed: 31046813
Crit Care Med. 2012 May;40(5):1546-53
pubmed: 22430242
Crit Care Med. 2020 Dec;48(12):1871-1880
pubmed: 33060502
Ann Am Thorac Soc. 2020 Oct;17(10):1326-1329
pubmed: 32716636
Crit Care Explor. 2020 Apr 29;2(4):e0088
pubmed: 32426730
Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44
pubmed: 16763220
J Gerontol. 1983 May;38(3):344-8
pubmed: 6841931
Nat Rev Dis Primers. 2020 Jul 15;6(1):60
pubmed: 32669623
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
J Crit Care. 2016 Oct;35:180-4
pubmed: 27481756
Crit Care Med. 2016 Sep;44(9):1744-53
pubmed: 27153046
Am J Respir Crit Care Med. 2018 Jan 1;197(1):66-78
pubmed: 28872898
Crit Care Med. 2018 Apr;46(4):594-601
pubmed: 29293149
Lancet Reg Health Eur. 2021 Feb;1:100005
pubmed: 34173618
Br J Psychiatry. 2017 Dec;211(6):388-395
pubmed: 29051176
Lancet Reg Health Eur. 2021 Jul;6:100121
pubmed: 34291229
Am J Crit Care. 2021 Feb 15;:e1-e5
pubmed: 33566061
Thorax. 2017 Sep;72(9):856-858
pubmed: 28213591
Crit Care. 2012 Oct 15;16(5):R192
pubmed: 23068129
Crit Care Explor. 2020 Nov 19;2(11):e0273
pubmed: 34124686
N Engl J Med. 2016 May 12;374(19):1831-41
pubmed: 27168433
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Crit Care Med. 2018 Sep;46(9):1522-1531
pubmed: 29957717
Crit Care Med. 2015 May;43(5):1112-20
pubmed: 25654174
Ann Am Thorac Soc. 2019 Oct;16(10):1304-1311
pubmed: 31184500
Ann Am Thorac Soc. 2019 Jul;16(7):894-909
pubmed: 30950647
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Thorax. 2022 Mar 21;:
pubmed: 35314485
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246

Auteurs

Joanne McPeake (J)

Intensive Care Unit, Glasgow Royal Infirmary, Glasgow, UK. Joanne.mcpeake@glasgow.ac.uk.
School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK. Joanne.mcpeake@glasgow.ac.uk.

Philip Henderson (P)

School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Pamela MacTavish (P)

Intensive Care Unit, Glasgow Royal Infirmary, Glasgow, UK.

Helen Devine (H)

Intensive Care Unit, Glasgow Royal Infirmary, Glasgow, UK.

Malcolm Daniel (M)

Intensive Care Unit, Glasgow Royal Infirmary, Glasgow, UK.

Phil Lucie (P)

Intensive Care Unit, University Hospital Wishaw, Wishaw, UK.

Lynn Bollan (L)

Intensive Care Unit, University Hospital Wishaw, Wishaw, UK.

Lucy Hogg (L)

Intensive Care Unit, NHS Fife, Kirkcaldy, UK.

Mike MacMahon (M)

Intensive Care Unit, NHS Fife, Kirkcaldy, UK.

Sharon Mulhern (S)

Intensive Care Unit, NHS Ayrshire and Arran, Kilmarnock, UK.

Pauline Murray (P)

Intensive Care Unit, NHS Ayrshire and Arran, Kilmarnock, UK.

Laura O'Neill (L)

Intensive Care Unit, University Hospital Monklands, Airdrie, UK.

Laura Strachan (L)

Intensive Care Unit, Queen Elizabeth University Hospital, Glasgow, UK.

Theodore J Iwashyna (TJ)

Center for Clinical Management Research, VA Ann Arbor Health System, Ann Arbor, MI, USA.
Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Martin Shaw (M)

School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
Clinical Physics, NHS Greater Glasgow and Clyde, Glasgow, UK.

Tara Quasim (T)

Intensive Care Unit, Glasgow Royal Infirmary, Glasgow, UK.
School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH